Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug Administration's top vaccine ...

Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...

Steep cuts at the Food and Drug Administration might slow down drug approvals vital to the biopharma industry.

Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.

Around 3,500 employees are on the chopping block at the Food and Drug Administration, but they don’t yet know who they are.

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...

Americans pay far more for GLP-1 drugs than citizens in other wealthy nations. If Dr. Marty Makary, the new FDA commissioner, ...

The same FDA that endlessly delays approving drugs gives a free pass to the counterfeit drugs. Copycat drugs can save ...

The top vaccine official with the Food and Drug Administration has resigned and criticized the nation's top health official ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

The Philippine Economic Zone Authority (PEZA) said Friday that a new ecozone in Tarlac will host the country’s first ...